Asset Lead (Director), Oncology Outcomes Research

At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe. Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office is purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects. Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we’re taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention. Do you have expertise in, and passion for Medical Affairs in Oncology ? AstraZeneca ’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm with the bold ambition to eliminate cancer as a cause of death. We are proud to work on ground breaking science with one of the broadest and deepest Oncology pipelines in the business. Help to advance our pipeline by applying expertise and accelerating our pathway to finding a cure. We are seeking an Asset Lead, Oncology Outcomes Research (O2R) who will report to the Tumor Lead for Oncology Outcomes Research. The Asset Lead will be responsible for developing and executing health outcomes and real-world strategies and studies on a global and US market level. The O2R team develops strategy for and delivers impactful real world, health outcomes, economic and patient reported research. The team's mission is to focus on quantifying and communicating the value proposition. In addition to evidence generation and communication, the team is a strong strategic partner to the Global and Regional medical teams responsible for developing health outcomes strategy in oncology. This position will be based at our vibrant campus location in Gaithersburg, MD. What You'll Do: • Leads the development and execution of the Global Franchise strategy including real world evidence, and other activities to assess, quantify and communicate the value proposition for AZ’s oncology portfolio. • Responsible for leading the development and execution of asset specific Global and US Regional health outcomes strategy. • Oversees a team of Outcomes Researchers, which will deliver both the strategy and technical execution of projects for that specific Franchise. • Responsible for strategically communicating and influencing a diverse group of internal and external collaborators in GMA, OBU and ORD. • Proactive relationship and communications with key counterparts in GMA, CMLT, USMA, EUCAN, OMAP, International. • Will manage, coach and mentor outcomes researchers with diverse technical skills and enable them to deliver impactful and measurable results. • Oversees the development of research plans for assets. • Participates in key internal review and governance meetings to ensure the scientific rigor of AZ sponsored research including ERT. ­­ Minimum Qualifications: • Minimum 5 years’ experience in the pharmaceutical industry • Expert knowledge and application of epidemiological/health outcomes methodology within pharmaceutical industry at an international level. • In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models. • Scientific expertise in oncology with knowledge of different data source